Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver condition, positive news for the drugmaker that lost more than one-third of i ...

NVIDIA、Novo Nordisk および DCAI と提携して創薬を推進 製薬業界の世界的なリーダーが、デンマークの企業、スタートアップ、公衆衛生システムと ...

Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity drug, with lower growth expected for its treatments in the second half of ...

原題： Novo Nordisk Smashes Past $500 Billion Value on Wegovy Fervor 、 Novo Nordisk Sees Up to 26% Sales Surge With Wegovy Rollout (2) （抜粋） ...